MatsukiyoCocokara & Co. FY2027 Q1 Earnings Report

Quick View

Executive Summary

In Q1 FY2027, the Company reported higher revenue and income, supported by the absorption of SG&A expenses and improved profit margins in addition to revenue growth. Revenue was ¥2893.5B (+5.7% YoY), Operating Income was ¥214.9B (+8.5%), Ordinary Income was ¥228.2B (+8.8%), and Net Income attributable to owners of the parent was ¥148.65B (+14.9%). The Operating Income margin improved to 7.4% from the previous-year period, and profit growth exceeding revenue growth indicates that operating leverage was realized.

Factors Affecting Results

【Revenue】Revenue increased 5.7% YoY to ¥2893.5B. The Matsumoto Kiyoshi Group Business, accounting for 63.6% of the revenue mix, increased 4.8% YoY, while the Cocokara Fine Group Business, accounting for 33.7%, was essentially flat at -0.0% YoY. The newly consolidated And Company Business, comprising Shinseido Pharmacy and Universal Drug, recorded revenue of ¥61.8B, with the expansion of the consolidation scope contributing to revenue growth.

【Profit and Loss】Operating Income increased 8.5% YoY to ¥214.9B. A gross margin of 35.7% more than absorbed the SG&A ratio of 28.3%, raising the profit margin. Profit margins improved in both core businesses: the Matsumoto Kiyoshi Group Business reached 8.8% (+approximately 0.6pt YoY), while the Cocokara Fine Group Business reached 5.6% (+approximately 0.5pt). Ordinary Income exceeded Operating Income by ¥13.4B, supported by non-operating income, including dividend income. Extraordinary gains and losses resulted in a net loss of ¥2.75B, including an impairment loss of ¥1.15B and a loss on disposal of non-current assets of ¥0.7B, which weighed on profit as a temporary factor. Nevertheless, Net Income recorded the highest growth rate at +14.9% YoY, supported by a lower tax burden. In conclusion, the Company achieved both revenue and income growth.

Segment Analysis

The Matsumoto Kiyoshi Group Business recorded revenue of ¥1838.9B (+4.8% YoY) and Operating Income of ¥161.0B (+12.3%), resulting in an 8.8% profit margin and achieving both revenue and income growth as well as margin improvement as the core business. The Cocokara Fine Group Business was essentially flat in revenue at ¥974.5B (-0.0% YoY), but Operating Income increased 9.0% to ¥54.4B, improving the profit margin to 5.6%. The And Company Business was newly recorded following the conversion of the relevant entities into consolidated subsidiaries, with revenue of ¥61.8B and Operating Income of ¥0.1B, and remains in the initial stage of integration. The Management Support Business recorded segment profit of ¥430.6B; however, most of this was offset by intersegment transaction eliminations of ¥431.2B, resulting in a limited substantive contribution to consolidated Operating Income. Accordingly, the Matsumoto Kiyoshi Group Business is regarded as the main business serving external customers.

Key Financial Metrics

【Profitability】The Operating Income margin was 7.4%, improving from approximately 7.2% in the previous-year period, as the gross margin of 35.7% exceeded and absorbed the SG&A ratio of 28.3%. The Net Income margin rose to 5.1% from approximately 4.7% in the previous-year period.【Cash Flow Quality】Comprehensive Income was ¥143.4B, slightly below Net Income of ¥149.6B, with the deterioration in the valuation difference on securities of ¥-6.8B being the primary cause of the difference.【Investment Efficiency】ROE, based on cumulative Q1 results, was 2.8%, while BPS was ¥1,365.01, essentially flat from ¥1,365.78 in the previous-year period. EPS increased 16.4% YoY to ¥37.59.【Financial Soundness】The Equity Ratio remained high at 73.0%. Total assets were ¥7369.5B and net assets were ¥5378.4B, indicating a solid capital base.

Cash Flow Analysis

As this report does not include detailed line items from the cash flow statement, fund flows are analyzed based on changes in the balance sheet. Cash and deposits were ¥1014.7B, down from ¥1197.5B in the previous-year period. Together with the decline in investment securities, from ¥289.7B to ¥231.6B, this suggests that funds may have been allocated to growth investments and the acquisition of consolidated subsidiaries. Meanwhile, short-term borrowings were minimal at ¥15.2B, indicating extremely limited reliance on interest-bearing debt. Accounts payable were ¥1209.9B, representing 72.0% of current liabilities, and working capital management utilizing supplier settlement terms supported liquidity. Inventories increased to ¥1664.5B from ¥1600.0B in the previous-year period, with inventory accumulation observed as one factor contributing to the decline in cash on hand.

Earnings Quality

Ordinary Income exceeded Operating Income by ¥13.4B; however, non-operating income was ¥13.6B, remaining below 0.5% of revenue and not large enough to materially distort the assessment of core earnings power. Extraordinary gains and losses resulted in a net loss of ¥2.75B. Against a gain on the sale of non-current assets of ¥1.5B, temporary expenses included an impairment loss of ¥1.15B and a loss on disposal of non-current assets of ¥0.7B. These items reflect the disposal of underperforming assets associated with the reorganization of the store network and should be distinguished from recurring earnings power. Comprehensive Income of ¥143.4B was slightly below Net Income of ¥149.6B, primarily due to the negative change of ¥-6.8B in the valuation difference on securities. However, the gap was small and did not materially impair earnings quality.

Earnings Forecast and Guidance

The Q1 progress rates against the full-year company forecasts were 25.1% for revenue, 24.6% for Operating Income, and 24.9% for Ordinary Income, all representing standard levels close to the simple progress benchmark of 25%. The full-year forecasts are revenue of ¥1.155T (+3.4% YoY) and Operating Income of ¥87.50B (+3.0%), while Q1 actual growth rates—revenue of +5.7% and Operating Income of +8.5%—exceeded the growth rates assumed in the full-year forecasts. As of the beginning of the fiscal year, progress was therefore favorable relative to the Company’s plan. No revisions were made to the earnings or dividend forecasts during the quarter.

Shareholder Returns

The full-year dividend forecast is ¥56.00 per share, and the forecast Payout Ratio calculated using the full-year EPS forecast of ¥149.18 is approximately 37.5%. This figure is a Payout Ratio calculated using dividends alone in the numerator and is not the Total Return Ratio, which includes share repurchases. A ratio of 37.5% is within a reasonable range relative to the earnings level, while the Equity Ratio of 73.0% and cash and deposits of ¥1014.7B support dividend stability.

Risk Factors

1. Inventory Turnover Efficiency: Inventories were ¥1664.5B, up from ¥1600.0B in the previous-year period, and inventory days exceed the general level for the retail industry. Slow-moving inventory could put pressure on the gross margin of 35.7% through markdowns and valuation losses.

2. Stagnant Revenue in the Cocokara Fine Group Business: External revenue in this business was essentially flat at -0.0% YoY. Although the profit margin improved, renewed revenue growth will be a key issue going forward.

3. Integration of Newly Consolidated Subsidiaries: Following the consolidation of Shinseido Pharmacy, Universal Drug, and AppBrew, realizing synergies in store operations, procurement, and systems integration may take time. The Operating Income margin of the And Company Business remained low at 0.2%.

Industry Benchmark (Reference; Company Analysis)

Industry Benchmark (retail)

Profitability and Returns

The Company’s Operating Income margin and Net Income margin both significantly exceeded the industry median, placing it among the industry leaders in terms of profitability.

Growth and Capital Efficiency

The revenue growth rate was slightly below the industry median. Relative to its high profitability, the Company’s growth pace remained around the middle of the industry.

※Source: Company analysis

Key Takeaways from the Financial Results

1. Operating Income growth of +8.5% exceeded revenue growth of +5.7%, and the Operating Income margin improved from the previous-year period. Margin improvement in both core businesses—the Matsumoto Kiyoshi Group Business and the Cocokara Fine Group Business—indicates a qualitative improvement in the earnings structure.

2. Q1 progress rates against the full-year forecasts were 25.1% for revenue and 24.6% for Operating Income, representing standard levels and indicating progress in line with the Company’s plan at this stage. The forecast Payout Ratio of approximately 37.5% is within a reasonable range relative to the earnings level.

3. Inventories increased YoY, making inventory efficiency an issue to monitor in terms of maintaining the gross margin going forward. Progress in integrating the newly consolidated subsidiaries comprising the And Company Business may also affect future margin trends.

Theoretical Share Price (Reference Value)

Sensitivity: ¥1,396–¥1,478 at ±1% for the cost of equity, and ¥1,435–¥1,439 at ±0.1 for ω.

Note:

• Net assets as of the quarter-end are used (there is a timing difference from the full-year forecast).

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee the future share price.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2027 Q1 was a solid start, with profit growth exceeding sales growth and the company tracking broadly in line with its full-year plan. Revenue rose 5.7% YoY to JPY289.3bn. Operating income increased 8.5% to JPY21.5bn, outpacing revenue and indicating modest operating leverage. Ordinary income grew 8.8% to JPY22.8bn. Profit attributable to owners rose 14.9% to JPY14.9bn, materially faster than operating income. Gross profit increased 9.6% YoY to JPY103.4bn. The gross margin improved to 35.7% from 34.5% in the prior-year quarter, an expansion of approximately 124bp. The operating margin increased to 7.4% from 7.2%, an improvement of approximately 19bp. The smaller operating-margin expansion relative to gross-margin expansion reflects higher SG&A spending, which grew 10.0% YoY and faster than revenue. Salaries and allowances increased 8.2% to JPY27.7bn, while rent expense increased 4.2% to JPY20.4bn. The Matsumotokiyoshi Group remained the core business, generating JPY183.7bn in external sales and JPY16.1bn in segment profit. The Cocokara Fine Group recorded broadly flat sales but improved segment profit, supporting consolidated earnings resilience. Newly consolidated entities contributed to expansion in the And Company and management-support businesses. Q1 operating-income progress against the full-year forecast was 24.6%, close to the standard 25% seasonal benchmark. Revenue progress was also normal at 25.1% of the annual forecast. Net income progress was 25.2%, consistent with the annual earnings target. The balance sheet remains conservatively funded, with a 229.3% current ratio, 130.2% quick ratio and only JPY1.5bn of reported interest-bearing debt. The principal operating watchpoint is the reported 82 inventory days, which is high relative to retail benchmarks and requires continued attention to merchandise productivity and markdown risk. The JPY100.2bn goodwill balance is meaningful but remains moderate at 18.6% of equity, limiting near-term balance-sheet dependence on acquired value retention. The FY2027 outlook depends on sustaining gross-margin gains, containing personnel and other operating costs, and realizing expected benefits from newly consolidated subsidiaries.

Profitability Analysis

Annualized ROE was 11.1%, placing returns within the 10-15% good benchmark range. The provided DuPont decomposition is net profit margin of 5.1%, annualized asset turnover of 1.571x and financial leverage of 1.37x. The earnings model is therefore primarily supported by retail operating margin and efficient asset utilization rather than aggressive leverage. Financial leverage is restrained, consistent with total liabilities representing 27.0% of total assets and reported debt/capital of 0.3%. Net margin expanded to 5.1% from approximately 4.7% in FY2026 Q1, driven by operating-income growth exceeding revenue growth and by a favorable comparison in special items. Gross margin expanded 124bp to 35.7%, above the 25-35% general-retail reference range and indicative of a favorable merchandise mix, pricing, procurement or private-brand contribution. EBIT margin was 7.4%, while the operating margin was also 7.4%, reflecting immaterial net interest expense. Interest coverage was exceptionally strong at 1,652.85x. The interest burden of 1.049 and minimal interest expense of JPY0.013bn confirm that debt servicing does not constrain profitability. The tax burden was 0.659, below the 0.70 normal reference level, corresponding to a 33.7% effective tax rate. SG&A rose 10.0% YoY to JPY81.9bn, versus 5.7% revenue growth, increasing the SG&A ratio by about 108bp to 28.3%. This SG&A increase absorbed most of the gross-margin improvement, although the resulting SG&A ratio remains within the 25-35% typical retail range. Salaries and allowances accounted for 33.8% of SG&A, making labor-cost control a central determinant of incremental margin. Rent was 7.1% of revenue, within the typical 5-10% retail range, but remains a material fixed-cost item. Recurring earnings quality is supported by ordinary income exceeding operating income by JPY1.3bn, primarily from non-operating income, while non-operating income represented only 0.5% of revenue and is not a major earnings driver. Net income grew faster than ordinary income partly because the prior period included a higher net special-loss burden; current-period extraordinary losses were JPY0.43bn, including JPY0.12bn of impairment and JPY0.24bn of store-closure loss, partly offset by JPY0.15bn in asset-sale gains.

Growth Assessment

Top-line growth of 5.7% was led by the Matsumotokiyoshi Group, whose external sales rose 4.9% YoY to JPY183.7bn. The core Matsumotokiyoshi Group's segment profit increased 12.3% to JPY16.1bn, implying a segment-margin improvement to 8.8% from 8.2%. Cocokara Fine Group external sales were essentially flat at JPY97.4bn, but segment profit increased 9.0% to JPY5.4bn and its segment margin improved to 5.6% from 5.1%. This indicates that profit growth was not solely dependent on network expansion, but also reflected improved profitability in the existing portfolio. The And Company business contributed JPY6.2bn of external sales following the addition of Shinseido Pharmacy and the consolidation of Universal Drug. The management-support business recorded JPY2.0bn of external sales, while its large segment-profit figure includes substantial internal transactions and is not directly comparable with external-sales profitability. Consolidated gross-profit growth of 9.6% exceeded revenue growth, providing the key foundation for operating-income expansion. Full-year guidance calls for 3.4% revenue growth and 3.0% operating-income growth. Q1 revenue and operating-income progress rates of 25.1% and 24.6%, respectively, are both within 0.4 percentage points of the standard 25% Q1 pace and do not indicate a material deviation from plan. Ordinary-income progress was 24.9% of full-year guidance, also consistent with the annual target. The Q1 net-income run rate was 25.2% of the annual forecast. Management has not revised earnings or dividend guidance. Continued growth will depend on preserving the gross-margin improvement while preventing personnel, systems, integration and store-related costs from rising faster than sales. The reported 82 inventory days is a meaningful constraint on growth quality because future sales expansion should not require a disproportionate increase in stocked merchandise.

Financial Health

Liquidity is strong, with current assets of JPY385.3bn against current liabilities of JPY168.0bn. The current ratio is 229.3%, well above the 1.0 warning threshold and the 1.5 healthy benchmark. The quick ratio is 130.2%, indicating that liquidity remains adequate even excluding inventories. Working capital was JPY217.2bn. Cash and deposits of JPY101.5bn covered reported short-term loans of JPY1.5bn by 66.93x. Total equity was JPY537.8bn and represented 73.0% of total assets, providing a substantial capital buffer. Total liabilities were JPY199.1bn, or 27.0% of assets. The reported debt-to-equity ratio was 0.37x, below the 1.0 conservative benchmark, while reported debt/capital was only 0.3%. There is no current-ratio or D/E threshold breach requiring a balance-sheet solvency warning. All reported interest-bearing debt is short term, producing the refinancing-risk quality alert. However, its absolute amount is minimal relative to cash, working capital and interest coverage, so the practical maturity-mismatch risk appears low; the relevant issue is the concentration of the small debt balance in short maturities rather than leverage capacity. Accounts payable of JPY121.0bn substantially support inventory funding and are typical within a retailer's supplier-financed working-capital model. Asset retirement obligations totaled JPY15.6bn, equivalent to 7.8% of liabilities and above the 5% quality-alert threshold. This reflects the long-term obligation associated with leased store sites and restoration requirements; it is structurally common in store-network retailing, but raises the importance of store-portfolio profitability and closure discipline. Goodwill was JPY100.2bn, equal to 18.6% of equity and 13.6% of assets, both within stated healthy ranges. Intangible assets represented 18.0% of assets, remaining below the 20% balanced-asset benchmark. The JPY0.12bn impairment loss was small relative to goodwill, but recurring monitoring of acquired-business performance and store-level cash generation remains relevant under JGAAP, where goodwill amortization reduces operating profit and net income.

Cash Flow Quality

Operating, investing and financing cash-flow figures are not provided in the financial data. Cash-based earnings conversion, free-cash-flow generation, and coverage of dividends and capital expenditure therefore cannot be quantified. Balance-sheet movements show cash and deposits declining by JPY18.3bn YoY to JPY101.5bn, while inventories increased by JPY6.5bn to JPY166.4bn. The inventory increase was modest in percentage terms at 4.0% and was lower than revenue growth, but the reported 82 inventory days remains above the 60-day retail warning threshold. The high-inventory-days alert is concerning because slower merchandise conversion can increase markdown, obsolescence and working-capital requirements, especially in cosmetics, health and seasonal product categories. For a drugstore and beauty retailer, this can be partly associated with category breadth, in-store availability requirements and promotional inventory, but 82 days still warrants monitoring against sales growth and gross-margin performance. Accounts receivable declined by JPY3.5bn YoY to JPY71.0bn, which partially offsets the inventory-related use of working capital. Accounts payable increased by JPY1.3bn YoY to JPY121.0bn, further supporting operating working capital. There is no evidence from the available balance-sheet data of an unusual receivables build-up. Customer-related contract liabilities increased to JPY5.0bn from JPY4.5bn, indicating a modest increase in advance customer-related balances. Point-card certificate provisions rose to JPY0.30bn from JPY0.25bn, consistent with continued loyalty-program activity. The absence of cash-flow data prevents assessment of whether reported profit is fully converted into cash or whether working-capital movements are masking pressure on underlying cash generation.

Dividend Sustainability

The full-year dividend forecast is JPY56.0 per share, with no revision announced. Using forecast EPS of JPY149.18, the implied dividend payout ratio is approximately 37.5%. This is below the 60% sustainability benchmark and leaves room for reinvestment, acquisitions, store investment and balance-sheet resilience. The forecast dividend is supported by annual net income guidance of JPY59.0bn and a large equity base of JPY537.8bn. The company has minimal reported interest-bearing debt and strong liquidity, which further supports financial flexibility. Dividend sustainability cannot be assessed against free cash flow because cash-flow and capital-expenditure figures are not provided. The relevant factors to monitor are cash conversion of earnings, inventory discipline, acquisition-related investment needs and goodwill impairment exposure. No share-buyback data is provided; therefore, no total return ratio is calculated.

Risk Assessment

Business risks include Inventory productivity risk: reported inventory days of 82 exceed the 60-day retail warning level. The likely root cause is a sizable JPY166.4bn merchandise base relative to sales, potentially reflecting broad drugstore/beauty assortment, stock availability and acquisition-related portfolio expansion. The impact is higher markdown, obsolescence and working-capital risk if consumer demand, cosmetics trends or seasonal sell-through weaken., Consumer and category-mix risk: earnings depend on maintaining a 35.7% gross margin in a competitive drugstore and beauty market. Changes in consumer discretionary spending, tourism-related demand, promotional intensity or product mix could reverse the 124bp gross-margin gain., Labor-cost risk: salaries and allowances rose 8.2% YoY, faster than revenue. Persistent wage inflation, staffing shortages and investment in store operations could limit further operating-margin expansion., Store-network profitability risk: current-period special losses included JPY0.24bn of store-closure loss and JPY0.12bn of impairment. These are small relative to operating income, but they indicate continued need for disciplined store portfolio management and lease-site optimization., Integration risk: newly consolidated Shinseido Pharmacy, Universal Drug and AppBrew expand the operating perimeter. Synergy realization, systems integration, merchandise alignment and retention of local customer relationships are key execution variables..

Financial risks include Refinancing-risk alert: 100% of reported interest-bearing debt is short term, above the 40% alert threshold. The root cause is the JPY1.5bn debt balance being entirely short-term. Its impact is currently limited because cash covers this balance by 66.93x, but short-term funding concentration should remain controlled if acquisition financing rises., Asset-retirement-obligation alert: asset retirement obligations of JPY15.6bn are 7.8% of total liabilities, above the 5% alert threshold. This is consistent with a leased-store retail model, but increases fixed obligations associated with store closures, relocations and lease exits., Acquired-asset risk: goodwill of JPY100.2bn and intangible assets of JPY133.0bn together account for 31.6% of assets. Goodwill/equity remains healthy at 18.6%, but future underperformance of acquired businesses could create amortization or impairment pressure under JGAAP., Tax-rate risk: the effective tax rate was 33.7%, producing a tax burden of 0.659. This is somewhat heavier than the stated normal tax-burden reference and limits translation of pre-tax profit growth into shareholder earnings..

Key concerns include Sustaining gross-margin expansion while SG&A grows faster than revenue., Reducing or stabilizing inventory days without compromising product availability and customer service., Converting acquisition-led sales additions into sustainable segment-margin expansion., Maintaining store-level returns and avoiding an increase in closure and impairment charges., Preserving strong liquidity if future M&A activity or network investment accelerates..

Investment Implications

Key takeaways include Revenue, operating income and owner-attributable profit increased 5.7%, 8.5% and 14.9% YoY, respectively., Gross margin improved 124bp to 35.7%, while operating margin improved 19bp to 7.4%., The Matsumotokiyoshi Group is the core business, contributing JPY183.7bn of external sales and JPY16.1bn of segment profit., Cocokara Fine delivered segment-profit growth despite essentially flat sales, evidencing improved profitability., Q1 progress versus full-year guidance is close to the standard seasonal pace: 25.1% for revenue and 24.6% for operating income., Liquidity and capitalization are strong, with a 229.3% current ratio, 73.0% equity ratio and very limited reported interest-bearing debt., Inventory days of 82 are the most material operational quality alert., Goodwill exposure is meaningful but remains moderate relative to equity at 18.6%..

Metrics to watch include Gross margin and operating margin, particularly whether gross-profit gains continue to exceed personnel and other SG&A growth., Inventory days, inventory growth relative to sales, and any inventory writedown or markdown charges., Same-store sales, customer traffic, ticket size and store productivity., Matsumotokiyoshi and Cocokara Fine segment sales and segment-profit margins., Profit contribution and integration progress from And Company and newly consolidated subsidiaries., Store-closure losses, impairment charges and asset retirement obligations., Cash conversion, free cash flow and dividend coverage once cash-flow data becomes available., Goodwill and intangible-asset trends following acquisitions..

Regarding relative positioning, The company combines specialty-retail-level gross margin of 35.7% with a typical retail SG&A ratio of 28.3%, generating a 7.4% operating margin and annualized 11.1% ROE without reliance on financial leverage. Its liquidity profile is stronger than that of a highly leveraged consolidator, while the main relative operational challenge is inventory efficiency, as the reported 82 inventory days exceed standard general-retail ranges.